180 related articles for article (PubMed ID: 35301393)
1. Intratumoral administration of the antisecretory peptide AF16 cures murine gliomas and modulates macrophage functions.
Kopecky J; Pérez JE; Eriksson H; Visse E; Siesjö P; Darabi A
Sci Rep; 2022 Mar; 12(1):4609. PubMed ID: 35301393
[TBL] [Abstract][Full Text] [Related]
2. Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response.
Sielska M; Przanowski P; Wylot B; Gabrusiewicz K; Maleszewska M; Kijewska M; Zawadzka M; Kucharska J; Vinnakota K; Kettenmann H; Kotulska K; Grajkowska W; Kaminska B
J Pathol; 2013 Jul; 230(3):310-21. PubMed ID: 23520016
[TBL] [Abstract][Full Text] [Related]
3. Programmed Cell Death 10 Mediated CXCL2-CXCR2 Signaling in Regulating Tumor-Associated Microglia/Macrophages Recruitment in Glioblastoma.
Zhang Q; Wang J; Yao X; Wu S; Tian W; Gan C; Wan X; You C; Hu F; Zhang S; Zhang H; Zhao K; Shu K; Lei T
Front Immunol; 2021; 12():637053. PubMed ID: 34108959
[TBL] [Abstract][Full Text] [Related]
4. HYBID derived from tumor cells and tumor-associated macrophages contribute to the glioblastoma growth.
Tsuji S; Nakamura S; Yamada T; de Vega S; Okada Y; Inoue S; Shimazawa M; Hara H
Brain Res; 2021 Aug; 1764():147490. PubMed ID: 33887254
[TBL] [Abstract][Full Text] [Related]
5. Syngeneic murine glioblastoma models: reactionary immune changes and immunotherapy intervention outcomes.
Letchuman V; Ampie L; Shah AH; Brown DA; Heiss JD; Chittiboina P
Neurosurg Focus; 2022 Feb; 52(2):E5. PubMed ID: 35104794
[TBL] [Abstract][Full Text] [Related]
6. Convection-enhanced delivery of temozolomide and whole cell tumor immunizations in GL261 and KR158 experimental mouse gliomas.
Enríquez Pérez J; Kopecky J; Visse E; Darabi A; Siesjö P
BMC Cancer; 2020 Jan; 20(1):7. PubMed ID: 31900109
[TBL] [Abstract][Full Text] [Related]
7. Correlation of MR-Based Metabolomics and Molecular Profiling in the Tumor Microenvironment of Temozolomide-Treated Orthotopic GL261 Glioblastoma in Mice.
Zhao K; Calero-Pérez P; Bopp MHA; Möschl V; Pagenstecher A; Mulero-Acevedo M; Vázquez M; Barcia C; Arús C; Nimsky C; Rusch T; Bartsch JW; Candiota AP
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139457
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy with subcutaneous immunogenic autologous tumor lysate increases murine glioblastoma survival.
Belmans J; Van Woensel M; Creyns B; Dejaegher J; Bullens DM; Van Gool SW
Sci Rep; 2017 Oct; 7(1):13902. PubMed ID: 29066810
[TBL] [Abstract][Full Text] [Related]
9. Tumor associated microglia/macrophages utilize GPNMB to promote tumor growth and alter immune cell infiltration in glioma.
Yalcin F; Haneke H; Efe IE; Kuhrt LD; Motta E; Nickl B; Flüh C; Synowitz M; Dzaye O; Bader M; Kettenmann H
Acta Neuropathol Commun; 2024 Apr; 12(1):50. PubMed ID: 38566120
[TBL] [Abstract][Full Text] [Related]
10. The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy.
Qian J; Wang C; Wang B; Yang J; Wang Y; Luo F; Xu J; Zhao C; Liu R; Chu Y
J Neuroinflammation; 2018 Oct; 15(1):290. PubMed ID: 30333036
[TBL] [Abstract][Full Text] [Related]
11. Differentiated glioblastoma cells accelerate tumor progression by shaping the tumor microenvironment via CCN1-mediated macrophage infiltration.
Uneda A; Kurozumi K; Fujimura A; Fujii K; Ishida J; Shimazu Y; Otani Y; Tomita Y; Hattori Y; Matsumoto Y; Tsuboi N; Makino K; Hirano S; Kamiya A; Date I
Acta Neuropathol Commun; 2021 Feb; 9(1):29. PubMed ID: 33618763
[TBL] [Abstract][Full Text] [Related]
12. Anti-PD-1 Induces M1 Polarization in the Glioma Microenvironment and Exerts Therapeutic Efficacy in the Absence of CD8 Cytotoxic T Cells.
Rao G; Latha K; Ott M; Sabbagh A; Marisetty A; Ling X; Zamler D; Doucette TA; Yang Y; Kong LY; Wei J; Fuller GN; Benavides F; Sonabend AM; Long J; Li S; Curran M; Heimberger AB
Clin Cancer Res; 2020 Sep; 26(17):4699-4712. PubMed ID: 32554515
[TBL] [Abstract][Full Text] [Related]
13. Deletion of the RNA regulator HuR in tumor-associated microglia and macrophages stimulates anti-tumor immunity and attenuates glioma growth.
Wang J; Leavenworth JW; Hjelmeland AB; Smith R; Patel N; Borg B; Si Y; King PH
Glia; 2019 Dec; 67(12):2424-2439. PubMed ID: 31400163
[TBL] [Abstract][Full Text] [Related]
14. Modulation of temozolomide dose differentially affects T-cell response to immune checkpoint inhibition.
Karachi A; Yang C; Dastmalchi F; Sayour EJ; Huang J; Azari H; Long Y; Flores C; Mitchell DA; Rahman M
Neuro Oncol; 2019 Jun; 21(6):730-741. PubMed ID: 30668768
[TBL] [Abstract][Full Text] [Related]
15. Combination anti-CXCR4 and anti-PD-1 immunotherapy provides survival benefit in glioblastoma through immune cell modulation of tumor microenvironment.
Wu A; Maxwell R; Xia Y; Cardarelli P; Oyasu M; Belcaid Z; Kim E; Hung A; Luksik AS; Garzon-Muvdi T; Jackson CM; Mathios D; Theodros D; Cogswell J; Brem H; Pardoll DM; Lim M
J Neurooncol; 2019 Jun; 143(2):241-249. PubMed ID: 31025274
[TBL] [Abstract][Full Text] [Related]
16. CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas.
Flores-Toro JA; Luo D; Gopinath A; Sarkisian MR; Campbell JJ; Charo IF; Singh R; Schall TJ; Datta M; Jain RK; Mitchell DA; Harrison JK
Proc Natl Acad Sci U S A; 2020 Jan; 117(2):1129-1138. PubMed ID: 31879345
[TBL] [Abstract][Full Text] [Related]
17. Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity.
Verschuere T; Toelen J; Maes W; Poirier F; Boon L; Tousseyn T; Mathivet T; Gerhardt H; Mathieu V; Kiss R; Lefranc F; Van Gool SW; De Vleeschouwer S
Int J Cancer; 2014 Feb; 134(4):873-84. PubMed ID: 23929302
[TBL] [Abstract][Full Text] [Related]
18. Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression.
De Boeck A; Ahn BY; D'Mello C; Lun X; Menon SV; Alshehri MM; Szulzewsky F; Shen Y; Khan L; Dang NH; Reichardt E; Goring KA; King J; Grisdale CJ; Grinshtein N; Hambardzumyan D; Reilly KM; Blough MD; Cairncross JG; Yong VW; Marra MA; Jones SJM; Kaplan DR; McCoy KD; Holland EC; Bose P; Chan JA; Robbins SM; Senger DL
Nat Commun; 2020 Oct; 11(1):4997. PubMed ID: 33020472
[TBL] [Abstract][Full Text] [Related]
19. Dicer deficiency impairs proliferation but potentiates anti-tumoral effect of macrophages in glioblastoma.
Liu YQ; Luo M; Shi Y; Guo Y; Zhang H; Yang KD; Li TR; Yang LQ; Liu TT; Huang B; Liu Q; He ZC; Zhang XN; Wang WY; Wang S; Zeng H; Niu Q; Zhang X; Cui YH; Zhang ZR; Bian XW; Ping YF
Oncogene; 2022 Jul; 41(30):3791-3803. PubMed ID: 35764885
[TBL] [Abstract][Full Text] [Related]
20. Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma.
Xu S; Wei J; Wang F; Kong LY; Ling XY; Nduom E; Gabrusiewicz K; Doucette T; Yang Y; Yaghi NK; Fajt V; Levine JM; Qiao W; Li XG; Lang FF; Rao G; Fuller GN; Calin GA; Heimberger AB
J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 24974128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
